Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, w...

Full description

Bibliographic Details
Main Authors:	Brad Evans, Erin Griner, Reproducibility Project: Cancer Biology
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2015-07-01
Series:	eLife
Subjects:	methodology Reproducibility Project: Cancer Biology IDH 2-hydroxyglutarate
Online Access:	https://elifesciences.org/articles/07420

Similar Items

Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
by: Oliver Fiehn, et al.
Published: (2016-02-01)

Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite
by: Raffaela S. Berger, et al.
Published: (2021-04-01)

The Emerging Role of D-2-Hydroxyglutarate as an Oncometabolite in Hematolymphoid and Central Nervous System Neoplasms
by: Dinesh eRakheja, et al.
Published: (2013-07-01)

The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation
by: Lizhen Liu, et al.
Published: (2021-01-01)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
by: Luyan Mu, et al.
Published: (2018-03-01)

The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas
by: Cara Reiter-Brennan, et al.
Published: (2018-12-01)

Quantitative imaging of D-2-hydroxyglutarate (D2HG) in selected histological tissue areas by a novel bioluminescence technique
by: Nadine Fabienne Voelxen, et al.
Published: (2016-03-01)

Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry
by: Rémi Longuespée, et al.
Published: (2018-03-01)

Oncometabolite D-2-Hydroxyglutarate enhances gene silencing through inhibition of specific H3K36 histone demethylases
by: Ryan Janke, et al.
Published: (2017-03-01)

Metabolic Rewiring and the Characterization of Oncometabolites
by: Diren Beyoğlu, et al.
Published: (2021-06-01)

The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites
by: Vivek A. Hariharan, et al.
Published: (2017-03-01)

Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner
by: Pavithra Viswanath, et al.
Published: (2018-04-01)

Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells
by: Zoltán Hujber, et al.
Published: (2017-06-01)

Replication Study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
by: Megan Reed Showalter, et al.
Published: (2017-06-01)

Registered report: IDH mutation impairs histone demethylation and results in a block to cell differentiation
by: Adam D Richarson, et al.
Published: (2016-03-01)

Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney
by: Garrett Brinkley, et al.
Published: (2020-11-01)

Registered report: Widespread potential for growth factor-driven resistance to anticancer kinase inhibitors
by: Edward Greenfield, et al.
Published: (2014-12-01)

The Roles of 2-Hydroxyglutarate
by: Xin Du, et al.
Published: (2021-03-01)

Hydroxyglutaric Acidemia
by: J Gordon Millichap
Published: (1992-09-01)

Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
by: Juan Huang, et al.
Published: (2019-06-01)

A Drosophila model of combined D-2- and L-2-hydroxyglutaric aciduria reveals a mechanism linking mitochondrial citrate export with oncometabolite accumulation
by: Hongde Li, et al.
Published: (2018-09-01)

Autism and Hydroxyglutaric Aciduria
by: J Gordon Millichap
Published: (2008-04-01)

Registered report: The CD47-signal regulated protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
by: Denise Chroscinski, et al.
Published: (2015-01-01)

L-2-hydroxyglutaric aciduria: A case report
by: Jović Nebojša J., et al.
Published: (2014-01-01)

D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells
by: Ines Ugele, et al.
Published: (2019-02-01)

Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
by: Israr Khan, et al.
Published: (2015-09-01)

Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth
by: Luyuan Li, et al.
Published: (2020-01-01)

GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas
by: Zoltán Hujber, et al.
Published: (2018-11-01)

Clinical, Neuroimaging, and Genetic Features of the Patients with L-2-Hydroxyglutaric Aciduria
by: Ebru Canda, et al.
Published: (2018-03-01)

Registered report: Intestinal inflammation targets cancer-inducing activity of the microbiota
by: Kate Eaton, et al.
Published: (2015-03-01)

Registered report: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
by: James Evans, et al.
Published: (2015-08-01)

Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data
by: Irawati Kandela, et al.
Published: (2015-05-01)

Registered report: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
by: Jake Lesnik, et al.
Published: (2016-01-01)

Molecular markers of gliomas : implications for diagnosis and new target therapies
by: Di Stefano, Anna Luisa
Published: (2017)

Registered report: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis
by: Steven Fiering, et al.
Published: (2015-07-01)

<i>IDH1</i> Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
by: Fabiana Crispo, et al.
Published: (2020-08-01)

mIDH-associated DNA hypermethylation in acute myeloid leukemia reflects differentiation blockage rather than inhibition of TET-mediated demethylation
by: Laura Wiehle, et al.
Published: (2017-09-01)

2-Hydroxyglutarate Metabolism Is Altered in an in vivo Model of LPS Induced Endotoxemia
by: Susan F. Fitzpatrick, et al.
Published: (2020-03-01)

Magnetic Resonance Spectroscopy for Detection of 2-Hydroxyglutarate as a Biomarker for IDH Mutation in Gliomas
by: Thomas Leather, et al.
Published: (2017-06-01)

Registered report: Interactions between cancer stem cells and their niche govern metastatic colonization
by: Francesca Incardona, et al.
Published: (2015-06-01)